138 related articles for article (PubMed ID: 20676692)
1. Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium.
Rianthavorn P; Ettenger RB; Salusky IB; Kuizon BD
Pediatr Nephrol; 2010 Nov; 25(11):2311-9. PubMed ID: 20676692
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone therapy in calcium-loaded rats with renal failure.
Sanchez CP; He YZ
Endocrinology; 2004 Jul; 145(7):3375-85. PubMed ID: 15044375
[TBL] [Abstract][Full Text] [Related]
3. Effect of sevelamer hydrochloride on bone in experimental uremic rats.
Kuwahara M; Inoshita S; Terada Y; Sasaki S
Ther Apher Dial; 2009 Feb; 13(1):42-8. PubMed ID: 19379169
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism.
Padagas J; Colloton M; Shalhoub V; Kostenuik P; Morony S; Munyakazi L; Guo M; Gianneschi D; Shatzen E; Geng Z; Tan HL; Dunstan C; Lacey D; Martin D
Calcif Tissue Int; 2006 Jan; 78(1):35-44. PubMed ID: 16362459
[TBL] [Abstract][Full Text] [Related]
6. Correction of hyperphosphatemia suppresses cardiac remodeling in uremic rats.
Yamazaki-Nakazawa A; Mizobuchi M; Ogata H; Kumata C; Kondo F; Ono N; Koiwa F; Uda S; Kinugasa E; Akizawa T
Clin Exp Nephrol; 2014 Feb; 18(1):56-64. PubMed ID: 23740131
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.
Neves KR; Graciolli FG; dos Reis LM; Pasqualucci CA; Moysés RM; Jorgetti V
Kidney Int; 2004 Dec; 66(6):2237-44. PubMed ID: 15569312
[TBL] [Abstract][Full Text] [Related]
8. Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency.
Miller MA; Chin J; Miller SC; Fox J
Bone; 1998 Sep; 23(3):257-66. PubMed ID: 9737348
[TBL] [Abstract][Full Text] [Related]
9. A potential kidney-bone axis involved in the rapid minute-to-minute regulation of plasma Ca2+.
Nordholm A; Mace ML; Gravesen E; Olgaard K; Lewin E
BMC Nephrol; 2015 Mar; 16():29. PubMed ID: 25885328
[TBL] [Abstract][Full Text] [Related]
10. Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin?
Ferreira JC; Ferrari GO; Neves KR; Cavallari RT; Dominguez WV; Dos Reis LM; Graciolli FG; Oliveira EC; Liu S; Sabbagh Y; Jorgetti V; Schiavi S; Moysés RM
PLoS One; 2013; 8(11):e79721. PubMed ID: 24236156
[TBL] [Abstract][Full Text] [Related]
11. Short-term effects of vitamin D3 and 1,25-dihydroxyvitamin D3 on osteomalacia in uremic rats fed a low calcium-low-phosphorus diet.
Weisbrode SE
Am J Pathol; 1981 Jul; 104(1):35-40. PubMed ID: 6266257
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hyperphosphatemia, secondary hyperparathyroidism and hypocalcemia with calcium carbonate favorably modulates vaccination response in uremic rats.
Hannula PM; Pörsti IH; Saha HH; Kalliovalkama J; Jolma PM; Kööbi P; Olander RM; Antonen JA
Clin Nephrol; 2004 Jun; 61(6):406-12. PubMed ID: 15224804
[TBL] [Abstract][Full Text] [Related]
13. Effect of fluoride and low versus high levels of dietary calcium on mRNA expression of osteoprotegerin and osteoprotegerin ligand in the bone of rats.
Yu J; Gao Y; Sun D
Biol Trace Elem Res; 2013 Jun; 152(3):387-95. PubMed ID: 23456427
[TBL] [Abstract][Full Text] [Related]
14. Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism.
Sanchez CP; He YZ
J Am Soc Nephrol; 2005 Apr; 16(4):929-38. PubMed ID: 15728789
[TBL] [Abstract][Full Text] [Related]
15. Hyperphosphatemia-induced hyperparathyroidism in 5/6 nephrectomized rats: development of a new animal model.
Jiang Y; Wang M
Chin Med J (Engl); 2008 Dec; 121(23):2440-3. PubMed ID: 19102965
[TBL] [Abstract][Full Text] [Related]
16. Growth plate cartilage formation and resorption are differentially depressed in growth retarded uremic rats.
Cobo A; López JM; Carbajo E; Santos F; Alvarez J; Fernández M; Weruaga A
J Am Soc Nephrol; 1999 May; 10(5):971-9. PubMed ID: 10232682
[TBL] [Abstract][Full Text] [Related]
17. Bone elongation in rats with renal failure and mild or advanced secondary hyperparathyroidism.
Sanchez CP; He YZ; Leiferman E; Wilsman NJ
Kidney Int; 2004 May; 65(5):1740-8. PubMed ID: 15086913
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E protection of obesity-enhanced vascular calcification in uremic rats.
Peralta-Ramírez A; Montes de Oca A; Raya AI; Pineda C; López I; Guerrero F; Diez E; Muñoz-Castañeda JR; Martinez J; Almaden Y; Rodríguez M; Aguilera-Tejero E
Am J Physiol Renal Physiol; 2014 Feb; 306(4):F422-9. PubMed ID: 24370590
[TBL] [Abstract][Full Text] [Related]
19. High-phosphorus diet maximizes and low-dose calcitriol attenuates skeletal muscle changes in long-term uremic rats.
Acevedo LM; López I; Peralta-Ramírez A; Pineda C; Chamizo VE; Rodríguez M; Aguilera-Tejero E; Rivero JL
J Appl Physiol (1985); 2016 May; 120(9):1059-69. PubMed ID: 26869708
[TBL] [Abstract][Full Text] [Related]
20. Regulation of parathyroid cell gene expression in experimental uremia.
Shvil Y; Naveh-Many T; Barach P; Silver J
J Am Soc Nephrol; 1990 Jul; 1(1):99-104. PubMed ID: 2104257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
